TCL Archive Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough? December 14, 2007
TCL Archive Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines January 13, 2012
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012